18 Oct 2012: Thermo Fisher Scientific is pleased to announce an ion chromatography (IC) method that meets all the requirements of the proposed U.S. Pharmacopeia monograph method for determining voriconazole related compound F in voriconazole. Application Note 1022: Determination of Voriconazole Related Compound F in Voriconazole Using IC demonstrates that this method is sensitive, repeatable, and accurate using the solvent-compatible anion-exchange column specified in the proposed monograph with chemically suppressed conductivity detection. Determination can be made in 5 mg/mL sample solutions containing as low as 0.002% voriconazole related compound F.
Voriconazole is a second-generation triazole antifungal approved by the U.S. Food and Drug Administration in 2002 for the treatment of invasive aspergilliosis and other serious fungal infections. Invasive aspergilliosis is a rapidly progressive and often fatal infection that occurs in severely immunosuppressed patients, recipients of bone marrow and organ transplants, and those undergoing chemotherapy.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of $12 billion, we have approximately 39,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through three premier brands, Thermo Scientific, Fisher Scientific and Unity™ Lab Services, which offer a unique combination of innovative technologies, convenient purchasing options and a single solution for laboratory operations management. Our products and services help our customers solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Visit www.thermofisher.com.
Chromatography
Social Media Contact Information
Sonya Pelia
Phone: +1 408 481 4172
[email protected]